Market research

VYNT Vyant Bio Inc

PINK USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 1M
P/E ratio: Not available
Analyst target: 5
Dividend yield: Not available
Beta: 0.56

Loading price history…

Profile

Company facts

Exchange: PINK
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: US92942V1098
Market cap: 1M
P/E ratio: Not available
Analyst target: 5
Dividend yield: Not available
Beta: 0.56

About

About Vyant Bio Inc

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about VYNT.

VYNT Vyant Bio Inc

Price & volume

Company facts

About Vyant Bio Inc

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet